EN DE

Gencell Ltd (GNCLF) Fair Value & Analysis

Industrials · US · Market cap $1.3M

GL Gencell Ltd logo Gencell Ltd GNCLF · US
Price$0.2500
Fair Value$0.1600
Upside-36.0%
Quality37/100
Watch Gencell Ltd for free, get notified when fair value or trend changes. Watch for free
Weak Growth
Loss-making · -192.0% net margin
negative free cash flow
Mixed vs. peers (4/8)
Narrow moat 4/100
Evidence: Low Range $0.1000 – $0.2000 Share as image

Fair value as of: Aug 18, 2026

From 1 valuation models · updated today

Share price +316.7% over the past month.

Below-average quality, and screening another 36% overvalued on our models.

What matters now

  • The price sits above even our optimistic bull case ($0.2000). The favourable scenario is already priced in.
  • Weak quality (37/100) and above fair value at the same time, the margin of safety is missing on both counts.
  • The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.
  • A fairly wide model range ($0.1000 to $0.2000) leaves room in how you read the outcome.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (5 years)

$21.65 $0.0012 Fair Value $0.1600 May 2021 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 18, 2026.

How to read this chart

60‑month range $0.0012 – $21.65 · fair‑value band $0.1000 – $0.2000 · the $0.2500 price screens above the $0.1600 fair value. Dashed = 300-day average. As of Aug 18, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Gencell Ltd (GNCLF) currently trades at $0.2500, while our model-based Fair Value estimate is $0.1600, implying the stock looks roughly 36.0% overvalued today. The Quality Score stands at 37/100 (below-average quality), in the Industrials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: low).

Trailing-twelve-month revenue stands at $10.0M. Revenue grew 157.2% year over year. It earns a return on equity of -87.7%. The balance sheet holds a net cash position of $2.9M. Fundamentals as of Aug 18, 2026

Our scenario range runs from $0.1000 (bear case) to $0.2000 (bull case); at $0.2500, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 17% below its 52-week high and 317% above its 52-week low, currently above its 200-day average. For context, the median of 10 Industrials peers we cover trades at -65% fair-value upside, at -36%, GNCLF screens cheaper than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence
Highest evidence
NCAV (Graham) $0.0900 $0.1300 $0.1900 50
All 1 models by family
Asset-Based
NCAV (Graham) $0.0900 $0.1300 $0.1900 50

Notify me when GNCLF reaches fair value

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.

Key figures & financial health

Revenue (TTM) $10.0M
Revenue growth (YoY) +157%
Net margin -192%
Return on equity -87.7%
Free cash flow −$9.3M FY2025
Operating margin -1,612%
More key figures
EPS (TTM) $-0.9000
Net cash $2.9M FY2025

Figures from reported company fundamentals · as of Aug 18, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 37/100

Of which business quality 38 · Market factors (momentum, volatility) 55

Profitability 2
Margins and returns on capital today
Quality Growth 7
Are margins and returns improving?
Cashflow 0
Earnings quality: real cash, not paper profit
Fin. Strength 72
Balance sheet, leverage, solvency risk
Investment 73
Disciplined investing over empire-building
Low Volatility 43
Calm price path (market factor)
Momentum 67
Price trend over the last 3–12 months (market factor)
52W Momentum 47
Distance to the 52-week high (market factor)
Net Issuance 100
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

Gencell Ltd engages in the development and production of fuel cell-based energy systems. It offers GenCell BOX, a long-duration backup power solution that provides source of 5kW backup power for telecom and critical communications applications; GenCell REX, a utility backup power solution that produces 5kW of emission-free electricity for substations during …

Full company description

Gencell Ltd engages in the development and production of fuel cell-based energy systems. It offers GenCell BOX, a long-duration backup power solution that provides source of 5kW backup power for telecom and critical communications applications; GenCell REX, a utility backup power solution that produces 5kW of emission-free electricity for substations during power outages; and GenCell FOX, an off-grid power solution for telecom, schools, homes, hospital, border protection, CCTV, water purification and pumps, and heating. The company also provides GENCELL EVOX, a grid independent EV charging station; and GenCell GEMS, a software application that enables customers to optimally control GenCell solutions with maximal operational intelligence, and other industrial applications. It operates in Israel, Mexico, Spain, Japan, Switzerland, the United States, Rumania, Germany, Italy, and Canada. Gencell Ltd was incorporated in 2011 and is headquartered in Petah Tikva, Israel.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

Gencell Ltd reported revenue of $1.9M in FY2025 versus $5.8M in FY2021, a compound −24.2%/yr. Reported net income was −$18.9M in FY2025.

Growth Quality 0/100
Revenue growth is weak, negative or inconsistent.
Latest Revenue (FY 2025)
$1.9M
Latest YoY
−80.0%
Avg. growth/yr (3Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
−36.4%
Avg. growth/yr (7Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
−2.4%
Revenue −24.2%/yr
FY21 $5.8M
FY22 $7.4M
FY23 $4.9M
FY24 $9.5M
FY25 $1.9M
Net income
FY21 −$21.1M
FY22 −$36.7M
FY23 −$28.3M
FY24 −$19.4M
FY25 −$18.9M

GNCLF screens 36% overvalued. Compare with Contemporary Amperex Technology Co →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Gencell Ltd Fair Value". https://www.fairvalue-calculator.com/stock/GNCLF

Peer Group

Electrical Equipment & Parts · 529 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 38 · Bottom 25%
Fair Value upside −36% · Above median
Return on assets -40% · Bottom 25%
Net margin (TTM) -192% · Bottom 25%
Revenue growth 157% · Top 25%

Valuation Multiples vs Electrical Equipment & Parts median · lower = cheaper

P/B 0.32× · Cheaper than 75% of peers
P/S (TTM) 0.13× · Cheaper than 75% of peers

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 0 · sector 0
FUTURE 100 · sector 58
PAST 0 · sector 26
HEALTH 0 · sector 97
DIVIDEND 0 · sector 23

VALUE 0: the price sits above our fair-value range.

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Electrical Equipment & Parts stocks, each showing price versus our Fair Value estimate (as of Aug 18, 2026).

Stock Price Fair Value vs Fair Value
Contemporary Amperex Technology Co 3750 HK$652.50 HK$394.19 -40%
Delta Electronics (Thailand) Public Company DELTA 269.00 THB 40.28 THB -85%
LG Energy Solution, Ltd 373220 365,500 KRW 201,455 KRW -45%
WEG S.A WEGE3 14,900 ARS 4,338 ARS -71%
Sungrow Power Supply Co 300274 ¥117.53 ¥123.83 +5%
HD Hyundai Electric Co 267260 782,000 KRW 371,133 KRW -53%
LS ELECTRIC Co 010120 206,500 KRW 29,594 KRW -86%
Hyosung Heavy Industries Corporation 298040 2,892,000 KRW 1,013,099 KRW -65%
Hitachi Energy India Limited POWERINDIA ₹35,800 ₹6,106 -83%
Polycab India Limited POLYCAB ₹9,289 ₹3,218 -65%

Compare Gencell Ltd with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Industrials stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is Gencell Ltd (GNCLF) overvalued or undervalued?
As of Aug 18, 2026, our model estimates a fair value of $0.1600 versus a price of $0.2500, about −36% (overvalued).
What is the fair value of GNCLF?
Our model-based fair value for Gencell Ltd is $0.1600 (as of Aug 18, 2026), built from audited fundamentals. The current price is $0.2500.
What is the quality score of GNCLF?
Gencell Ltd has a Quality Score of 37/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of Gencell Ltd (GNCLF)?
Gencell Ltd reported trailing-twelve-month revenue of about $10.0M (latest available figure, as of Aug 18, 2026).
What is the net profit margin of GNCLF?
The net profit margin of Gencell Ltd is about -192.0%, meaning it is currently running at a net loss. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track Gencell Ltd and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.